Drug intelligence / Profile preview

Rowachol

Development stage
Phase 4
Lead developer
Rowa
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Rowachol is an oral pharmaceutical preparation composed of a mixture of monoterpenes, including pinene, camphene, cineole, menthone, menthol, and borneol in olive oil. It is primarily indicated for the treatment of hepato-biliary disorders such as cholelithiasis (gallstones), cholecystitis (gallbladder inflammation), cholangitis (bile duct inflammation), bile duct dyskinesia, and other inflammatory hepatic conditions[1][5][6]. The drug acts by increasing biliary secretion (choleresis), relieving spasm of the bile ducts, enhancing metabolic liver function by reducing biliary stasis, and inhibiting HMG-CoA reductase to reduce endogenous cholesterol production. This mechanism helps maintain bile above saturation level with respect to cholesterol—facilitating gallstone dissolution and preventing new stone formation[2][6][8]. Rowachol also supports insulin production and may be used as supportive therapy in mild diabetes[5][6]. It is sometimes used in combination with chenodeoxycholic acid for gallstone dissolution[2]. **Developers:** Rowa **Manufacturers:** Rowa

Brand names
Rowachol
Other names
terpene extract
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on Rowachol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rowachol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call